Cargando…
Clinical safety and efficacy of vitamin D3 analog ointment for treatment of obstructive meibomian gland dysfunction
BACKGROUND: Hyperkeratinization is a major cause of obstructive meibomian gland dysfunction (oMGD) and results in degenerative gland dilation and atrophy without inflammation. Ointment containing 1,25-dihydroxy-22-oxavitamin D3 (maxacalcitol), a noncalcemic analog of the active form of vitamin D3, i...
Autores principales: | Arita, Reiko, Kawashima, Motoko, Ito, Masataka, Tsubota, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463421/ https://www.ncbi.nlm.nih.gov/pubmed/28592257 http://dx.doi.org/10.1186/s12886-017-0482-7 |
Ejemplares similares
-
A New Modified Experimental Meibomian Gland Injury Model: Partial Loss of Gland Due to Orifice Cauterization and the Alleviating Potential of 22-Oxacalcitriol
por: Jin, Kai, et al.
Publicado: (2020) -
Investigation of Meibomian Gland Function and Dry Eye Disease in Patients with Graves’ Ophthalmopathy †
por: Inoue, Sachiko, et al.
Publicado: (2020) -
Proposed Algorithm for Management of Meibomian Gland Dysfunction Based on Noninvasive Meibography
por: Arita, Reiko, et al.
Publicado: (2020) -
Topical diquafosol for patients with obstructive meibomian gland dysfunction
por: Arita, Reiko, et al.
Publicado: (2013) -
Relation of Dietary Fatty Acids and Vitamin D to the Prevalence of Meibomian Gland Dysfunction in Japanese Adults: The Hirado–Takushima Study
por: Fukuoka, Shima, et al.
Publicado: (2021)